Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamara S Rodems

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Seminars in Cell & Developmental Biology|January 26, 2016
Adaptive responses to antibody based therapyTamara S Rodems, Mari Iida, Toni M Brand, et al.
Clinical Epigenetics|March 11, 2022
SEEMLIS: a flexible semi-automated method for enrichment of methylated DNA from low-input samplesTamara S Rodems, Duane S Juang, Charlotte N Stahlfeld, et al.
Medical Oncology (Northwood, London, England)|September 28, 2021
Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signalingErika Heninger, David Kosoff, Tamara S Rodems, et al.
Communications Biology|September 1, 2022
Reversible epigenetic alterations regulate class I HLA loss in prostate cancerTamara S Rodems, Erika Heninger, Charlotte N Stahlfeld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2020
AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck CancerNellie K McDaniel, Mari Iida, Kwangok P Nickel, et al.
Molecular Oncology|February 19, 2021
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinomaRory M Bade, Jennifer L Schehr, Hamid Emamekhoo, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Seminars in Cell & Developmental Biology|January 26, 2016
Adaptive responses to antibody based therapyTamara S Rodems, Mari Iida, Toni M Brand, et al.
Clinical Epigenetics|March 11, 2022
SEEMLIS: a flexible semi-automated method for enrichment of methylated DNA from low-input samplesTamara S Rodems, Duane S Juang, Charlotte N Stahlfeld, et al.
Medical Oncology (Northwood, London, England)|September 28, 2021
Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signalingErika Heninger, David Kosoff, Tamara S Rodems, et al.
Communications Biology|September 1, 2022
Reversible epigenetic alterations regulate class I HLA loss in prostate cancerTamara S Rodems, Erika Heninger, Charlotte N Stahlfeld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2020
AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck CancerNellie K McDaniel, Mari Iida, Kwangok P Nickel, et al.
Molecular Oncology|February 19, 2021
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinomaRory M Bade, Jennifer L Schehr, Hamid Emamekhoo, et al.
Pageof 1